Viewing Study NCT02382757


Ignite Creation Date: 2025-12-24 @ 6:56 PM
Ignite Modification Date: 2026-03-04 @ 10:39 AM
Study NCT ID: NCT02382757
Status: TERMINATED
Last Update Posted: 2015-03-09
First Post: 2015-03-03
Is Gene Therapy: True
Has Adverse Events: False

Brief Title: Changing Diabetes in Children
Sponsor: Novo Nordisk A/S
Organization:

Study Overview

Official Title: Changing Diabetes in Children (CDiC): Type 1 Diabetes in Economically Underprivileged Children in India
Status: TERMINATED
Status Verified Date: 2015-02
Last Known Status: None
Delayed Posting: No
If Stopped, Why?: Not Stopped
Has Expanded Access: False
If Expanded Access, NCT#: N/A
Has Expanded Access, NCT# Status: N/A
Acronym: CDiC
Brief Summary: This study is conducted in Asia. The primary objective of the CDiC programme is to improve access to comprehensive diabetes care among the children with diabetes from the economically underprivileged section of the population and to establish a registry for this group of children with type 1 diabetes in India.
Detailed Description: None

Study Oversight

Has Oversight DMC: False
Is a FDA Regulated Drug?: None
Is a FDA Regulated Device?: None
Is an Unapproved Device?: None
Is a PPSD?: None
Is a US Export?: None
Is an FDA AA801 Violation?:

Secondary ID Infos

Secondary ID Type Domain Link View
U1111-1149-2666 OTHER WHO View